HSP90B1 and cancer: The measurements with this ELISA actually proved that Grp94-IgG complexes were statistically more elevated in cancer patients with respect to healthy control subjects (Figure 2B), showing in addition that the site of tumor did not influence significantly the value of Grp94-IgG complexes.